Home › Research › Risk factors
Toward ‘net zero’ hysterectomy for Australia; New Zealand is already heading there…
Rebecca Deans, Jason Anthony Abbott. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2022-02-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Hysterectomy is often recommended for gynaecological symptomatology because menstruation inevitably ceases, and the mortality rate associated with this operation is low3. Despite high levels of control with oral medications, an American College of Obstetricians and Gynecologists practice bulletin states that within a period of ten years 46% of those using medicines for AUB ultimately underwent surgery, and hysterectomy is the most effective method to end abnormal uterine bleeding.6 Studies have shown that the levonorgestrel-releasing intrauterine system (LNG-IUS) is more effective than cyclical norethisterone – and with better compliance.7, 8 In the only randomised study with five-year follow-up, there were no differences in quality of life or psychological scores comparing LNG-IUS vs hysterectomy, despite 42% of patients treated with LNG-IUS subsequently undergoing this procedure.9 Timely management of the underlying pathology of AUB may negate the necessity for hysterectomy. Disappointingly in Australia, hysterectomy was over-represented in regional, compared to metropolitan areas,10 where limited access to primary health services due to geographical barriers, and socioeconomic factors reduced access to conservative treatments such as myomectomy and endometrial ablation. Uterine artery embolisation and endometrial ablation do not achieve the same definitive reduction in bleeding as hysterectomy.11, 12 But complications with these techniques are rare compared to those following hysterectomy, particularly in the rural setting where admission rates for this surgery were three-fold those observed in the major cities.10 The Clinical Care Standards from the Australian Commission On Safety And Quality In Health Care present an evidence-based assessment on the choices available to treat AUB and arose as a direct result of the variations identified. There are data that have shown a decreasing durability for sustained symptomatic improvement following surgery for pain, with conservative laparoscopic excisional surgery leading to reoperation in 1/3 women up to five years after initial surgery.13 This has been compared to a lower rate of reintervention when hysterectomy is performed in association with removal of endometriosis.14 Despite improvement in symptoms, with significantly fewer post-surgical operations occurring in the hysterectomy groups irrespective at stage of disease, pain may continue or recur, and we do need to abandon the term 'definitive' – since it
What this study adds
Evidence grade: High
This is a follow-up (cohort) study. This paper discusses hysterectomy for abnormal uterine bleeding, noting that the levonorgestrel-releasing intrauterine system was more effective than cyclical norethisterone with better compliance. Reported effect size: 11.4%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Deans, R., & Abbott, J. A. (2022). Toward ‘net zero’ hysterectomy for Australia; New Zealand is already heading there…. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13478
Vancouver
Deans R, Abbott JA. Toward ‘net zero’ hysterectomy for Australia; New Zealand is already heading there…. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2022. doi:10.1111/ajo.13478. PMID: 35174876.
BibTeX
@article{deans2022-35174876,
author = {Deans, Rebecca and Abbott, Jason Anthony},
title = {{Toward ‘net zero’ hysterectomy for Australia; New Zealand is already heading there…}},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2022},
doi = {10.1111/ajo.13478},
pmid = {35174876},
url = {https://doi.org/10.1111/ajo.13478}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Hysterectomy is often recommended for gynaecological symptomatology because menstruation inevitably ceases, and the mortality rate associated with this operation is low3.
- Despite high levels of control with oral medications, an American College of Obstetricians and Gynecologists practice bulletin states that within a period of ten years 46% of those using medicines for AUB ultimately underwent surgery, and hysterectomy is the most effective method to end abnormal uterine bleeding.6 Studies have shown that the levonorgestrel-releasing intrauterine system (LNG-IUS) is more effective than cyclical norethisterone – and with better compliance.7, 8 In the only randomised study with five-year follow-up, there were no differences in quality of life or psychological scores comparing LNG-IUS vs hysterectomy, despite 42% of patients treated with LNG-IUS subsequently undergoing this procedure.9 Timely management of the underlying pathology of AUB may negate the necessity for hysterectomy.
- Disappointingly in Australia, hysterectomy was over-represented in regional, compared to metropolitan areas,10 where limited access to primary health services due to geographical barriers, and socioeconomic factors reduced access to conservative treatments such as myomectomy and endometrial ablation.
- Uterine artery embolisation and endometrial ablation do not achieve the same definitive reduction in bleeding as hysterectomy.11, 12 But complications with these techniques are rare compared to those following hysterectomy, particularly in the rural setting where admission rates for this surgery were three-fold those observed in the major cities.10 The Clinical Care Standards from the Australian Commission On Safety And Quality In Health Care present an evidence-based assessment on the choices available to treat AUB and arose as a direct result of the variations identified.
- There are data that have shown a decreasing durability for sustained symptomatic improvement following surgery for pain, with conservative laparoscopic excisional surgery leading to reoperation in 1/3 women up to five years after initial surgery.13 This has been compared to a lower rate of reintervention when hysterectomy is performed in association with removal of endometriosis.14 Despite improvement in symptoms, with significantly fewer post-surgical operations occurring in the hysterectomy groups irrespective at stage of disease, pain may continue or recur, and we do need to abandon the term 'definitive' – since it certainly isn't.
Why it matters
This paper discusses hysterectomy for abnormal uterine bleeding, noting that the levonorgestrel-releasing intrauterine system was more effective than cyclical norethisterone with better compliance. It also notes that in Australia hysterectomy was over-represented in regional compared to metropolitan areas where limited access to primary health services reduced access to conservative treatments.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designcohort study
- Effect size11.4%
- Evidence strengthHigh
How this study scored 48/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Australian and New Zealand Journal of Obstetrics and Gynaecology) |
| Journal's citation record | 1 / 4 | Australian and New Zealand Journal of Obstetrics and Gynaecology: journal h-index 100 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 8 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 2 / 6 | Cited 1.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Jason Anthony Abbott: h-index 53 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | UNSW Sydney: institution h-index 1,101 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35174876) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also in Risk factors
356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.